基于保险类型的髋骨关节炎治疗时间与治疗方式是否存在差异
利用2011至2019年全国理赔数据库,按保险类型(医疗补助管理式医疗、联邦医疗保险优势计划、商业保险)比较髋骨关节炎患者接受全髋关节置换术(THA)或非手术干预的比例及至THA的时间。医疗补助患者3年内THA发生率较低(7.4% vs 10.9%或12.0%,P<.0001),至手术时间较长(297天 vs 215天或261天,P<.0001),多变量分析中接受THA的比值比亦较低。
要点
- 医疗补助患者3年内THA发生率为7.4%,低于联邦医疗保险优势计划的10.9%或商业保险的12.0%(P<.0001)。
- 医疗补助患者至THA时间为297天,长于联邦医疗保险优势计划的215天或商业保险的261天(P<.0001)。
- 多变量分析中医疗补助患者接受THA的OR为0.62(95%CI 0.60-0.64)对比联邦医疗保险优势计划,OR为0.63(95%CI 0.61-0.64)对比商业保险。
核心结论
- 医疗补助患者较联邦医疗保险优势计划或商业保险患者THA发生率更低、至THA时间更长。
- 需进一步调查这些差异的原因(如费用或就医障碍)以确保公平医疗。
研究设计与样本
- 使用全国理赔数据库识别2011至2019年髋骨关节炎接受THA或非手术干预的患者,按保险类型分为医疗补助管理式医疗、联邦医疗保险优势计划和商业保险三组。
- 主要结局为髋骨关节炎诊断后3年内THA发生率,采用多变量逻辑回归模型评估THA与保险类型的关联,调整年龄、性别、地区和合并症。
主要发现
- 医疗补助患者3年内THA发生率为7.4%,联邦医疗保险优势计划为10.9%,商业保险为12.0%(P<.0001)。
- 医疗补助患者至THA时间为297天,联邦医疗保险优势计划为215天,商业保险为261天(P<.0001)。
- 多变量分析中,医疗补助患者接受THA的OR为0.62(95%CI 0.60-0.64)对比联邦医疗保险优势计划,OR为0.63(95%CI 0.61-0.64)对比商业保险。
- 医疗补助患者接受非手术干预的OR为0.92(95%CI 0.91-0.94)对比联邦医疗保险优势计划,OR为0.81(95%CI 0.79-0.82)对比商业保险。
局限性
- 需进一步调查这些差异的原因(如费用或就医障碍)以确保公平医疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Disparities in care access based on insurance exist for total hip arthroplasty (THA), but it is unclear if these lead to longer times to surgery. We evaluated whether rates of THA versus nonoperative interventions (NOI) and time to THA from initial hip osteoarthritis (OA) diagnosis vary by insurance type. METHODS: Using a national claims database, patients who had hip OA undergoing THA or NOI from 2011 to 2019 were identified and divided by insurance type: Medicaid-managed care; Medicare Advantage; and commercial insurance. The primary outcome was THA incidence within 3 years after hip OA diagnosis. Multivariable logistic regression models were created to assess the association between THA and insurance type, adjusting for age, sex, region, and comorbidities. RESULTS: Medicaid patients had lower rates of THA within 3 years of initial diagnosis (7.4 versus 10.9 or 12.0%, respectively; P < .0001) and longer times to surgery (297 versus 215 or 261 days, respectively; P < .0001) compared to Medicare Advantage and commercially-insured patients. In multivariable analyses, Medicaid patients were also less likely to receive THA (odds ratio (OR) = 0.62 [95% confidence intervals (CI): 0.60 to 0.64] versus Medicare Advantage, OR = 0.63 [95% CI: 0.61 to 0.64] versus commercial) or NOI (OR = 0.92 [95% CI: 0.91 to 0.94] versus Medicare Advantage, OR = 0.81 [95% CI: 0.79 to 0.82] versus commercial). CONCLUSIONS: Medicaid patients experienced lower rates of and longer times to THA than Medicare Advantage or commercially-insured patients. Further investigation into causes of these disparities, such as costs or access barriers, is necessary to ensure equitable care.
引用
- Chakraborty A, Zhuang T, Shapiro LM, et al. Is There Variation in Time to and Type of Treatment for Hip Osteoarthritis Based on Insurance? J Arthroplasty. 2023. PMID: 37778640. doi:10.1016/j.arth.2023.09.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。